Back to results
US 2012/0237567 A1Published application
Modulating lymphatic function
AssigneeThe General Hospital Corporation
InventorsJeroen Hagendoorn, Dai Fukumura, Timothy P. Padera, Rakesh K. Jain
Life of this patent
Estimating the term…
Abstract
Methods and compositions for modulating lymphatic function, e.g., by altering NO levels, are disclosed.
Claims7
A method of treating a subject in need of decreased lymphatic flow, the method comprising
- identifying a subject in need of decreased lymphatic flow, and
- administering to the subject an endothelial nitric oxide synthase (eNOS) inhibitor in an amount effective to decrease lymphatic flow.
Dependencies are inferred from the claim text.